tci Medicare Compliance & Reimbursement - 2006 Issue 36
PRESCRIPTION DRUGS: Your Patients Need Better Access To Drugs Under Part D, Groups Say
Subscribe or sign in to view the full article.
Article Overview
This article reports on patient advocacy groups’ federal policy priorities related to prescription drug access and safety. It discusses requests for increased NIH funding, concerns about Medicare Part D implementation from the patient perspective, and calls for FDA-related actions tied to drug safety, approval resources, and patient access. The piece is useful for readers tracking health policy, patient advocacy, and broad federal programs affecting prescription drug coverage and regulation.
Why This Topic Matters
The article helps stakeholders understand patient-group concerns about prescription drug coverage and safety policy at the federal level. It is relevant to anyone monitoring Medicare Part D, NIH appropriations, or FDA drug-safety and approval issues affecting chronic-condition care.
What You Will Learn
- The main federal policy areas addressed by patient advocacy groups
- How patient groups framed concerns about Medicare Part D access
- Why NIH funding and FDA policy were included in the discussion
- What kinds of broad access and safety issues patient organizations highlighted
Who Should Read This
- Medical coders
- Health policy analysts
- Compliance professionals
- Healthcare administrators
- Patient advocacy organizations
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com